Human and Animal Health Internal Pipeline

Human and Animal Health Pipeline

iBio uses the FastPharming System to quickly produce biotherapeutic and vaccine candidates for unmet medical needs.

In the area of human disease, IBIO-100 targets fibrosis, a leading cause of organ failure worldwide. IBIO-200 is a virus-like particle (VLP) vaccine designed as a rapid medical countermeasure solution to the COVID-19 outbreak. IBIO-201 is a vaccine targeting COVID-19 that uses iBio's patented LicKM platform .

Additionally, iBio is developing a candidate vaccine for classical swine fever, an agricultural disease so severe that infected pig herds are destroyed to prevent spread. The IBIO-400 program has demonstrated complete protection in live-virus challenge studies while providing an ability to discriminate between infected and vaccinated animals (DIVA).